164 related articles for article (PubMed ID: 20532957)
1. A biomarker of mercury body-burden correlated with diagnostic domain specific clinical symptoms of autism spectrum disorder.
Kern JK; Geier DA; Adams JB; Geier MR
Biometals; 2010 Dec; 23(6):1043-51. PubMed ID: 20532957
[TBL] [Abstract][Full Text] [Related]
2. A prospective blinded evaluation of urinary porphyrins verses the clinical severity of autism spectrum disorders.
Geier DA; Kern JK; Geier MR
J Toxicol Environ Health A; 2009; 72(24):1585-91. PubMed ID: 20077233
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of environmental toxicity and susceptibility in autism.
Geier DA; Kern JK; Garver CR; Adams JB; Audhya T; Nataf R; Geier MR
J Neurol Sci; 2009 May; 280(1-2):101-8. PubMed ID: 18817931
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of mercury toxicity biomarkers in autistic spectrum disorders.
Geier DA; Geier MR
J Toxicol Environ Health A; 2007 Oct; 70(20):1723-30. PubMed ID: 17885929
[TBL] [Abstract][Full Text] [Related]
5. Porphyrinuria in childhood autistic disorder: implications for environmental toxicity.
Nataf R; Skorupka C; Amet L; Lam A; Springbett A; Lathe R
Toxicol Appl Pharmacol; 2006 Jul; 214(2):99-108. PubMed ID: 16782144
[TBL] [Abstract][Full Text] [Related]
6. Porphyrinuria in Korean children with autism: correlation with oxidative stress.
Youn SI; Jin SH; Kim SH; Lim S
J Toxicol Environ Health A; 2010; 73(10):701-10. PubMed ID: 20391113
[TBL] [Abstract][Full Text] [Related]
7. Are urinary porphyrins a valid diagnostic biomarker of autism spectrum disorder?
Shandley K; Austin DW; Bhowmik JL
Autism Res; 2014 Oct; 7(5):535-42. PubMed ID: 24756868
[TBL] [Abstract][Full Text] [Related]
8. Modeling clinical outcome of children with autistic spectrum disorders.
Coplan J; Jawad AF
Pediatrics; 2005 Jul; 116(1):117-22. PubMed ID: 15995041
[TBL] [Abstract][Full Text] [Related]
9. Altered urinary porphyrins and mercury exposure as biomarkers for autism severity in Egyptian children with autism spectrum disorder.
Khaled EM; Meguid NA; Bjørklund G; Gouda A; Bahary MH; Hashish A; Sallam NM; Chirumbolo S; El-Bana MA
Metab Brain Dis; 2016 Dec; 31(6):1419-1426. PubMed ID: 27406246
[TBL] [Abstract][Full Text] [Related]
10. A review of candidate urinary biomarkers for autism spectrum disorder.
Wang L; Angley MT; Gerber JP; Sorich MJ
Biomarkers; 2011 Nov; 16(7):537-52. PubMed ID: 22022826
[TBL] [Abstract][Full Text] [Related]
11. Toxicity biomarkers in autism spectrum disorder: a blinded study of urinary porphyrins.
Kern JK; Geier DA; Adams JB; Mehta JA; Grannemann BD; Geier MR
Pediatr Int; 2011 Apr; 53(2):147-53. PubMed ID: 20626635
[TBL] [Abstract][Full Text] [Related]
12. Etiologic yield of autistic spectrum disorders: a prospective study.
Battaglia A; Carey JC
Am J Med Genet C Semin Med Genet; 2006 Feb; 142C(1):3-7. PubMed ID: 16419094
[TBL] [Abstract][Full Text] [Related]
13. Is urinary indolyl-3-acryloylglycine a biomarker for autism with gastrointestinal symptoms?
Wang L; Angley MT; Gerber JP; Young RL; Abarno DV; McKinnon RA; Sorich MJ
Biomarkers; 2009 Dec; 14(8):596-603. PubMed ID: 19697973
[TBL] [Abstract][Full Text] [Related]
14. Autism spectrum disorders at 20 and 42 months of age: stability of clinical and ADI-R diagnosis.
Cox A; Klein K; Charman T; Baird G; Baron-Cohen S; Swettenham J; Drew A; Wheelwright S
J Child Psychol Psychiatry; 1999 Jul; 40(5):719-32. PubMed ID: 10433406
[TBL] [Abstract][Full Text] [Related]
15. A Comparison of the Autism Treatment Evaluation Checklist (ATEC) and the Childhood Autism Rating Scale (CARS) for the Quantitative Evaluation of Autism.
Geier DA; Kern JK; Geier MR
J Ment Health Res Intellect Disabil; 2013 Oct; 6(4):255-267. PubMed ID: 23914277
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
17. Clinic attenders with autism or attention-deficit/hyperactivity disorder: cognitive profile at school age and its relationship to preschool indicators of language delay.
Hagberg BS; Miniscalco C; Gillberg C
Res Dev Disabil; 2010; 31(1):1-8. PubMed ID: 19713073
[TBL] [Abstract][Full Text] [Related]
18. Specifying PDD-NOS: a comparison of PDD-NOS, Asperger syndrome, and autism.
Walker DR; Thompson A; Zwaigenbaum L; Goldberg J; Bryson SE; Mahoney WJ; Strawbridge CP; Szatmari P
J Am Acad Child Adolesc Psychiatry; 2004 Feb; 43(2):172-80. PubMed ID: 14726723
[TBL] [Abstract][Full Text] [Related]
19. Regression of language and non-language skills in pervasive developmental disorders.
Meilleur AA; Fombonne E
J Intellect Disabil Res; 2009 Feb; 53(2):115-24. PubMed ID: 19054269
[TBL] [Abstract][Full Text] [Related]
20. Variability in outcome for children with an ASD diagnosis at age 2.
Turner LM; Stone WL
J Child Psychol Psychiatry; 2007 Aug; 48(8):793-802. PubMed ID: 17683451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
